DE2238536C2 - Zubereitungen zur Behandlung von Mikrobeninfektionen - Google Patents

Zubereitungen zur Behandlung von Mikrobeninfektionen

Info

Publication number
DE2238536C2
DE2238536C2 DE2238536A DE2238536A DE2238536C2 DE 2238536 C2 DE2238536 C2 DE 2238536C2 DE 2238536 A DE2238536 A DE 2238536A DE 2238536 A DE2238536 A DE 2238536A DE 2238536 C2 DE2238536 C2 DE 2238536C2
Authority
DE
Germany
Prior art keywords
dmhp
sqx
ppm
compounds
infected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2238536A
Other languages
German (de)
English (en)
Other versions
DE2238536A1 (de
Inventor
James Joseph Burchall
Stanley Robert Morris Research Triangle Park N.C. Bushby
Robert Langton Tunbridge Wells Kent Cullen
Michael John William Crowborough Sussex Dunkley
Robert Research Triangle Park N.C. Ferone
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of DE2238536A1 publication Critical patent/DE2238536A1/de
Application granted granted Critical
Publication of DE2238536C2 publication Critical patent/DE2238536C2/de
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D475/00Heterocyclic compounds containing pteridine ring systems
    • C07D475/02Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • C07D475/04Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525Isoalloxazines, e.g. riboflavins, vitamin B2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Fodder In General (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE2238536A 1971-08-05 1972-08-04 Zubereitungen zur Behandlung von Mikrobeninfektionen Expired DE2238536C2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB3677471 1971-08-05
GB3581772A GB1405246A (en) 1971-08-05 1972-08-01 Potentiated antimicrobial compositions

Publications (2)

Publication Number Publication Date
DE2238536A1 DE2238536A1 (de) 1973-02-22
DE2238536C2 true DE2238536C2 (de) 1984-11-29

Family

ID=26262869

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2238536A Expired DE2238536C2 (de) 1971-08-05 1972-08-04 Zubereitungen zur Behandlung von Mikrobeninfektionen

Country Status (14)

Country Link
JP (1) JPS6036409B2 (US07696358-20100413-C00002.png)
BE (1) BE787236A (US07696358-20100413-C00002.png)
CS (1) CS172956B2 (US07696358-20100413-C00002.png)
DE (1) DE2238536C2 (US07696358-20100413-C00002.png)
FR (1) FR2150733B1 (US07696358-20100413-C00002.png)
GB (1) GB1405246A (US07696358-20100413-C00002.png)
HU (1) HU170534B (US07696358-20100413-C00002.png)
IE (1) IE36867B1 (US07696358-20100413-C00002.png)
IL (1) IL40050A (US07696358-20100413-C00002.png)
IT (1) IT1057861B (US07696358-20100413-C00002.png)
LU (1) LU65857A1 (US07696358-20100413-C00002.png)
NL (1) NL7210719A (US07696358-20100413-C00002.png)
NO (1) NO139004C (US07696358-20100413-C00002.png)
SE (1) SE434337B (US07696358-20100413-C00002.png)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1451043A (en) * 1972-08-01 1976-09-29 Wellcome Found Biologicylly acitve compounds and compositions
GB1454165A (en) * 1972-08-01 1976-10-27 Wellcome Found Biologically active compounds and compositions
GB1469521A (en) * 1973-01-05 1977-04-06 Wellcome Found Antimicrobial preparations
GB1596044A (en) * 1977-04-14 1981-08-19 Wellcome Found Veterinary compositions
AU572792B2 (en) * 1982-09-20 1988-05-19 Wellcome Foundation Limited, The 2-amino, 4-oxo-pteridine derivatives
JPS63121616U (US07696358-20100413-C00002.png) * 1987-01-30 1988-08-08
CN113897413A (zh) * 2021-10-12 2022-01-07 广州达安基因股份有限公司 一种体外诊断试剂防腐剂及其用途

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NICHTS-ERMITTELT

Also Published As

Publication number Publication date
GB1405246A (en) 1975-09-10
DE2238536A1 (de) 1973-02-22
NO139004C (no) 1978-12-20
NO139004B (no) 1978-09-11
IL40050A0 (en) 1972-10-29
NL7210719A (US07696358-20100413-C00002.png) 1973-02-07
SE434337B (sv) 1984-07-23
IT1057861B (it) 1982-03-30
HU170534B (US07696358-20100413-C00002.png) 1977-06-28
FR2150733B1 (US07696358-20100413-C00002.png) 1975-06-20
BE787236A (fr) 1973-02-05
JPS4828610A (US07696358-20100413-C00002.png) 1973-04-16
IE36867B1 (en) 1977-03-16
LU65857A1 (US07696358-20100413-C00002.png) 1973-02-01
FR2150733A1 (US07696358-20100413-C00002.png) 1973-04-13
JPS6036409B2 (ja) 1985-08-20
IE36867L (en) 1973-02-05
IL40050A (en) 1976-02-29
CS172956B2 (US07696358-20100413-C00002.png) 1977-01-28

Similar Documents

Publication Publication Date Title
DE60107835T2 (de) Medizinische zusammensetzungen zur förderung der aktivierung der eingeweide
EP0240829B1 (de) Cancerostatisches Mittel
DE69519031T2 (de) Neue Antibiotika und ihre enthaltende antibiotische Zusammensetzungen für die Inhibition gram positiven Bakterien und Mykoplasmen.
DE60202278T2 (de) Aktivierung natürlicher killerzellen durch adenosin-a3-rezeptoragonisten
DE3500179C2 (US07696358-20100413-C00002.png)
DE3603577A1 (de) Neue substituierte 2,4-diamino-5-benzylpyrimidine, deren herstellung und deren verwendung als arzneimittel mit antibakterieller wirksamkeit
DE2238536C2 (de) Zubereitungen zur Behandlung von Mikrobeninfektionen
EP0153617B1 (de) 1-[4-(Benzothia- oder -oxazol-2-ylthio- oder -2-yloxy) phenyl]-1,3,5-triazin-2,4,6(1H,3H,5H)-trione, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
EP0158075A1 (de) Immunstimulierende Mittel
DE2836373A1 (de) Purin-derivate
DE1933112C3 (de) Substituierte 1,3-Bis-(benzylidenamino)-guanidine
DE2814202C2 (de) Verwendung von Uracilderivaten zur Bekämpfung von Krebs oder krebsartigen Erkrankungen
US4795639A (en) Potentiating formulations
DE2404594A1 (de) Biologisch wirksame verbindungen und zubereitungen und verfahren zu ihrer herstellung
DE2338788A1 (de) Pteridinderivate, verfahren zu ihrer herstellung und ihre verwendung in pharmazeutischen zubereitungen
GB1574105A (en) Antimalarial compositions containing quinoline methanol derivatives
DE2338787A1 (de) Biologisch wirksame verbindungen und zubereitungen
DE3509949C2 (de) Verbindungen und deren Verwendung zur Behandlung von Protozoeninfektionen
US4073786A (en) 2-Amino-4-hydroxy-6-hydroxymethyl-7,7-diethyl-7,8-dihydropteridine and the 7-spirocyclohexyl analogue thereof
DE2404593A1 (de) Biologisch wirksame verbindungen
US4036961A (en) Pharmaceutical compositions containing pteridines
DE2005255C3 (de) Verwendung von Ca-5-butylpicolinat und/oder Ca-5-pentylpicolinat zur Herstellung eines blutdrucksenkenden Arzneimittels
EP0051852B1 (de) Pyrimido(4,5b)(1,4)thiazine und Verfahren zu ihrer Herstellung
EP1448179A1 (de) Substituierte bicyclo 3.3.1 nonan-2,4,9-trione als pharmazeutische wirkstoffe
DE2420779A1 (de) 3-substituierte 4,5-dihydro-1,2,4oxadiazole

Legal Events

Date Code Title Description
OD Request for examination
Q176 The application caused the suspense of an application

Ref document number: 2404594

Country of ref document: DE

AG Has addition no.

Ref country code: DE

Ref document number: 2404594

Format of ref document f/p: P

D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee